Nesmeyanova, V.S.; Ushkalenko, N.D.; Olkin, S.E.; Kosenko, M.N.; Rukhlova, E.A.; Susloparov, I.M.; Shcherbakov, D.N.
Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? Pharmaceutics 2025, 17, 1463.
https://doi.org/10.3390/pharmaceutics17111463
AMA Style
Nesmeyanova VS, Ushkalenko ND, Olkin SE, Kosenko MN, Rukhlova EA, Susloparov IM, Shcherbakov DN.
Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? Pharmaceutics. 2025; 17(11):1463.
https://doi.org/10.3390/pharmaceutics17111463
Chicago/Turabian Style
Nesmeyanova, Valentina S., Nikita D. Ushkalenko, Sergei E. Olkin, Maksim N. Kosenko, Elena A. Rukhlova, Ivan M. Susloparov, and Dmitry N. Shcherbakov.
2025. "Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies?" Pharmaceutics 17, no. 11: 1463.
https://doi.org/10.3390/pharmaceutics17111463
APA Style
Nesmeyanova, V. S., Ushkalenko, N. D., Olkin, S. E., Kosenko, M. N., Rukhlova, E. A., Susloparov, I. M., & Shcherbakov, D. N.
(2025). Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? Pharmaceutics, 17(11), 1463.
https://doi.org/10.3390/pharmaceutics17111463
